FBXO4 and neoplasm: For example, the presence of Fbxo4 mutations disrupts its ability to dimerize and to form the SCF complex in ESCC tumor specimens, and the existence of a substrate-binding deficient Fbxo4, Isoleucine (Ile)-377 to methionine mutant, in melanoma cells [79].